» Articles » PMID: 36651621

Mistuned NF-κB Signaling in Lymphocytes: Lessons from Relevant Inborn Errors of Immunity

Overview
Date 2023 Jan 18
PMID 36651621
Authors
Affiliations
Soon will be listed here.
Abstract

Inborn errors of immunity (IEIs) continuously remind us that multiple checks and balances are built into the adaptive immune system to maintain homeostasis, ensuring effective pathogen defense without causing inadvertent immunopathology, autoimmunity, or lymphomagenesis. The nuclear factor of κB (NF-κB) family of transcription factors serve a vital role in the immune system, inducing scores of genes responsible for lymphocyte survival, proliferation, differentiation and effector function. In recent years, the discovery and characterization of IEIs that impact NF-κB activity have illuminated the importance of carefully tuning this pathway to ensure effective immune defense without hyperinflammation and immune dysregulation. Here we examine several illustrative cases of IEIs that arise from pathogenic mutations encoding NF-κB inducers, regulators, and NF-κB family components themselves, illuminating how these genes ensure normal adaptive immune system function by maintaining a "Goldilocks effect" state in NF-κB pathway activity.

Citing Articles

Inborn errors of immunity: the Goldilocks effect-susceptibility to disease due to a little too much or a little too little.

Ma C, Tangye S Clin Exp Immunol. 2023; 212(2):93-95.

PMID: 37042727 PMC: 10128157. DOI: 10.1093/cei/uxad039.

References
1.
Pannicke U, Baumann B, Fuchs S, Henneke P, Rensing-Ehl A, Rizzi M . Deficiency of innate and acquired immunity caused by an IKBKB mutation. N Engl J Med. 2013; 369(26):2504-14. DOI: 10.1056/NEJMoa1309199. View

2.
Tangye S, Al-Herz W, Bousfiha A, Cunningham-Rundles C, Franco J, Holland S . Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2022; 42(7):1473-1507. PMC: 9244088. DOI: 10.1007/s10875-022-01289-3. View

3.
Shields A, Bauman B, Hargreaves C, Pollard A, Snow A, Patel S . A Novel, Heterozygous Three Base-Pair Deletion in CARD11 Results in B Cell Expansion with NF-κB and T Cell Anergy Disease. J Clin Immunol. 2020; 40(2):406-411. DOI: 10.1007/s10875-019-00729-x. View

4.
Boone D, Turer E, Lee E, Ahmad R, Wheeler M, Tsui C . The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat Immunol. 2004; 5(10):1052-60. DOI: 10.1038/ni1110. View

5.
Cuvelier G, Rubin T, Junker A, Sinha R, Rosenberg A, Wall D . Clinical presentation, immunologic features, and hematopoietic stem cell transplant outcomes for IKBKB immune deficiency. Clin Immunol. 2018; 205:138-147. PMC: 7106064. DOI: 10.1016/j.clim.2018.10.019. View